BIOATLA INC
BCAB
BCAB was delisted on the 28th of August, 2026.
73 hedge funds and large institutions have $192M invested in BIOATLA INC in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 25 closing their positions.
360% more call options, than puts
Call options by funds: $3.34M | Put options by funds: $726K
186% more capital invested
Capital invested by funds: $67.1M → $192M (+$124M)
0.06% more ownership
Funds ownership: 1.31% → 1.37% (+0.06%)
4% less funds holding
Funds holding: 76 → 73 (-3)
12% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 25
17% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$10M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$5.2M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.01M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$3.76M |
| 5 |
Morgan Stanley
New York
|
+$3.72M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$9.2M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$2.94M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
-$2.35M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.94M |
| 5 |
Two Sigma Investments
New York
|
-$1.49M |
BCAB Hedge Fund Activity: Q3 2022 in Review
73 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in BIOATLA INC (BCAB) for Q3 2022, worth a combined $192M — up 186% from $67.1M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of BCAB and 22 opened new positions — a net loss of 3 holders — while 23 trimmed existing stakes and 19 added.
The largest buyer was Candriam SCA, adding an estimated $10M. The largest seller was Tang Capital Management, cutting an estimated $9.2M.
- 73 institutional investors held BIOATLA INC (BCAB) as of Q3 2022, down from 76 in Q2 2022.
- Funds reported $192M of BIOATLA INC stock for Q3 2022, up 186% quarter-over-quarter.
- 22 funds opened new BIOATLA INC positions in Q3 2022 and 25 closed out, a net change of -3 holders.
- The largest BIOATLA INC buyer in Q3 2022 was Candriam SCA, an estimated $10M added.
- The largest BIOATLA INC seller in Q3 2022 was Tang Capital Management, an estimated $9.2M sold.
Based on aggregated 13F filings for Q3 2022.